|
Market Closed -
OTC Markets
03:59:40 2026-10-22 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.0250 USD | -21.88% |
|
-24.92% | -3.85% |
| May. 18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Nov. 17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -21.88% | -24.92% | -4.94% | -12.28% | -3.85% | -65.52% | -95.58% | -99.52% | -99.52% | 6.63M | |
| +2.83% | +4.40% | +11.67% | +12.35% | +21.59% | +60.84% | +123.50% | +436.08% | +1,569.89% | 1,165B | |
| +3.81% | +5.66% | -0.59% | +4.69% | +29.31% | +38.70% | +74.91% | +63.46% | +135.90% | 645B | |
| +0.14% | +0.63% | +7.53% | +12.59% | +24.82% | +24.71% | +95.03% | +161.31% | +367.68% | 504B | |
| -0.38% | +2.95% | +7.49% | +11.70% | +18.95% | +43.74% | +64.34% | +9.28% | +69.22% | 380B | |
| -1.76% | +1.41% | -2.43% | +15.51% | +39.88% | +68.06% | +43.41% | +81.44% | +140.59% | 363B | |
| -0.76% | +2.52% | +8.71% | +0.14% | +16.64% | +22.31% | +51.29% | +65.98% | +71.37% | 297B | |
| -1.86% | +2.27% | +2.40% | +0.32% | -7.70% | +1.86% | +26.02% | +42.34% | +162.38% | 269B | |
| +2.04% | +3.05% | +9.03% | +22.19% | +36.65% | +51.12% | +60.42% | +113.76% | +182.18% | 237B | |
| +2.36% | -0.11% | +2.96% | +20.60% | +28.07% | +29.42% | +102.04% | +133.77% | +111.59% | 195B | |
| -0.93% | +1.10% | +4.04% | -18.06% | -19.31% | -23.48% | -61.53% | -22.96% | +86.07% | 175B | |
| +1.91% | +3.33% | +8.92% | +22.56% | +22.17% | +23.06% | -0.75% | -29.52% | -5.47% | 173B | |
| +2.03% | +5.19% | +3.92% | +13.25% | +18.05% | +25.50% | +47.89% | +191.61% | +562.67% | 133B | |
| +3.08% | +4.01% | +1.20% | +3.69% | +16.80% | +41.92% | +11.58% | +9.38% | +25.95% | 129B | |
| -0.31% | +1.37% | +13.59% | +24.36% | +23.41% | +27.24% | +123.57% | +384.16% | +528.67% | 118B | |
| -1.04% | +1.67% | +0.41% | -0.62% | +3.79% | +15.01% | +29.49% | +6.34% | -7.68% | 103B | |
| -0.79% | +3.38% | +1.72% | -2.61% | -10.09% | -14.13% | -24.35% | -13.05% | +7.47% | 101B | |
| -17.57% | -14.32% | +10.99% | +248.94% | +587.11% | +654.67% | +152.03% | -37.95% | - | 80.9B | |
| +1.67% | +2.86% | +1.89% | +25.79% | +6.12% | +40.08% | +1.31% | +43.11% | +125.32% | 81.79B | |
| -2.05% | -0.62% | +7.86% | +2.98% | +16.97% | +24.43% | -1.00% | -29.43% | +45.70% | 71.29B | |
| Average | -1.37% | +0.28% | +4.82% | +20.40% | +43.47% | +54.48% | +41.18% | +75.48% | +214.74% | 261.05B | |
| Weighted average by Cap. | -0.37% | +2.75% | +5.99% | +13.64% | +29.04% | +46.85% | +69.18% | +154.73% | +481.86% |
- Stock Market
- Stocks
- ADAPY Stock
- Sector Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
